Viewing StudyNCT00134134



Ignite Creation Date: 2024-05-05 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00134134
Status: COMPLETED
Last Update Posted: 2006-09-11
First Post: 2005-08-23

Brief Title: Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa
Sponsor: NYU Langone Health
Organization: NYU Langone Health

Conditions & Keywords Data

Conditions:
Name
Hidradenitis Suppurativa
Keywords:
Name View
Raptiva View
hidradenitis suppurativa View
efalizumab View
biologic View